Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Trimuda Nuansa Citra Tbk. (TNCA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Trimuda Nuansa Citra Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Trimuda Nuansa Citra Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Trimuda Nuansa Citra Tbk. trades at Rp163 (market cap 69.99B, 6.77M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 9.1× Trimuda Nuansa Citra Tbk.'s market cap, and Trimuda Nuansa Citra Tbk. is more actively traded (6.77M versus 843K). Which is the better fit depends on your goals.

LABSTNCA
Market Cap
635.95B69.99B
Volume
843K6.77M
Lot
8.43K67.74K
Turnover
137.6M1.17B
Average Price
163.22173.21
Value
137.6M1.17B
Indicative Equilibrium Price
165163
Indicative Equilibrium Volume
246327

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
TNCA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Trimuda Nuansa Citra Tbk.

PT Trimuda Nuansa Citra Tbk(the Company) was established in Indonesia in accordance with Deed of Establishment of Limited Liability Company Company No. 21 dated May 4, 1995 made before H. Asmawel Amin, S.H., Notary in Jakarta.

Read more on TNCA